SABCS24 Archives | Cancer Today

Delaying Treatment Resistance

Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.

by Thomas Celona
Rethinking the Role of Radiation

Chest radiation may not be necessary for people with intermediate-risk breast cancer.

by Thomas Celona
De-escalating Treatment for DCIS

Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.

by Thomas Celona

Cancer Talk

A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.

by Kyle Bagenstose

Preliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.

by Sandra Gordon

Potential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.

by Taneia Surles

Experts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.

by Thomas Celona

Support for Cancer Today has been provided in part by an independent educational grant from Merck & Co., Inc.

All editorial content is produced independently by the Cancer Today editorial team.

Cancer Talk Archive

Cancer Talk Topics

From the AACR

Ultraproccessed Foods and Cancer Risk

The idea that ultraprocessed foods are associated with increased risk of metabolic and cardiovascular diseases is well supported, but what does the evidence reveal about these foods and cancer?
What Are the Benefits of Exercise for Cancer Patients?

Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.

Video

Cancer Research at a Crossroads